SGMT
Sagimet Biosciences Inc. Series A Common StockstockNASDAQ
Market OpenNov 19, 2026 3:44:11 PM EST
9.67USD-4.352%(-0.44)620,948
Pre-marketNov 19, 2026 9:28:30 AM EST
10.00USD-1.088%(-0.11)
SGMT Financials
In Q3 FY 2026 (ended ), Sagimet Biosciences Inc. Series A Common Stock (SGMT) reported net income of −$19.15M, operating cash flow of −$12.11M, and assets of $282.09M (filed ).
Loading financial flows…